INOVIO PHARMACEUTICALS, INC. Equity Method Investments
INOVIO PHARMACEUTICALS, INC. (INO) had Equity Method Investments of $0 as of 2021-12-31, per its 10-K filed 2022-03-01.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Long-Term Investments › Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures
us-gaap:EquityMethodInvestments · last filed 2022-03-01
- 2021-12-31: Equity Method Investments $0.00.
- 2021-09-30: Equity Method Investments $0.00.
- 2021-06-30: Equity Method Investments $0.00.
- 2021-03-31: Equity Method Investments $0.00.
| Period end | Equity Method Investments |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-01 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-09 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-09 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-10 |
| 2020-12-31 | $434.39K 10-K · filed 2022-03-01 |
| 2020-09-30 | $957.57K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $2.72M 10-Q · filed 2020-08-10 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-01 |
| 2016-06-30 | $5.30M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $5.00M 10-Q · filed 2016-05-09 |
| 2015-09-30 | $7.10M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $0.00 10-Q · filed 2015-08-10 |
| 2014-05-31 | $0.00 10-Q · filed 2017-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |